nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesoridazine—DRD3—Parkinson's disease	0.227	0.283	CbGaD
Mesoridazine—HTR1A—Parkinson's disease	0.185	0.231	CbGaD
Mesoridazine—DRD2—Parkinson's disease	0.157	0.196	CbGaD
Mesoridazine—HTR2A—Parkinson's disease	0.122	0.151	CbGaD
Mesoridazine—CYP2D6—Parkinson's disease	0.111	0.138	CbGaD
Mesoridazine—DRD3—telencephalic ventricle—Parkinson's disease	0.00563	0.0719	CbGeAlD
Mesoridazine—HTR2A—enteric nervous system—Parkinson's disease	0.00502	0.0641	CbGeAlD
Mesoridazine—HTR2A—myenteric nerve plexus—Parkinson's disease	0.0038	0.0486	CbGeAlD
Mesoridazine—HTR2A—locus ceruleus—Parkinson's disease	0.00331	0.0423	CbGeAlD
Mesoridazine—HTR2C—telencephalic ventricle—Parkinson's disease	0.00313	0.04	CbGeAlD
Mesoridazine—HTR2A—cerebellar cortex—Parkinson's disease	0.0027	0.0345	CbGeAlD
Mesoridazine—HTR1A—telencephalic ventricle—Parkinson's disease	0.00264	0.0337	CbGeAlD
Mesoridazine—HTR2A—sympathetic nervous system—Parkinson's disease	0.00262	0.0335	CbGeAlD
Mesoridazine—DRD2—telencephalic ventricle—Parkinson's disease	0.00238	0.0304	CbGeAlD
Mesoridazine—HTR2A—pons—Parkinson's disease	0.00191	0.0244	CbGeAlD
Mesoridazine—HTR2A—autonomic nervous system—Parkinson's disease	0.00176	0.0225	CbGeAlD
Mesoridazine—HTR2A—telencephalic ventricle—Parkinson's disease	0.00157	0.0201	CbGeAlD
Mesoridazine—DRD2—nerve—Parkinson's disease	0.0015	0.0192	CbGeAlD
Mesoridazine—HTR6—forebrain—Parkinson's disease	0.00141	0.0181	CbGeAlD
Mesoridazine—HTR2A—peripheral nervous system—Parkinson's disease	0.00127	0.0162	CbGeAlD
Mesoridazine—HTR1A—hindbrain—Parkinson's disease	0.00124	0.0159	CbGeAlD
Mesoridazine—DRD2—hindbrain—Parkinson's disease	0.00112	0.0144	CbGeAlD
Mesoridazine—HTR2A—nerve—Parkinson's disease	0.00099	0.0126	CbGeAlD
Mesoridazine—CHRM2—forebrain—Parkinson's disease	0.000848	0.0108	CbGeAlD
Mesoridazine—HTR2C—brainstem—Parkinson's disease	0.000847	0.0108	CbGeAlD
Mesoridazine—DRD3—head—Parkinson's disease	0.000842	0.0108	CbGeAlD
Mesoridazine—HTR2C—forebrain—Parkinson's disease	0.000818	0.0104	CbGeAlD
Mesoridazine—HTR6—head—Parkinson's disease	0.00081	0.0104	CbGeAlD
Mesoridazine—DRD3—nervous system—Parkinson's disease	0.000798	0.0102	CbGeAlD
Mesoridazine—DRD3—central nervous system—Parkinson's disease	0.000768	0.00982	CbGeAlD
Mesoridazine—HTR6—nervous system—Parkinson's disease	0.000768	0.00981	CbGeAlD
Mesoridazine—HTR2A—hindbrain—Parkinson's disease	0.000741	0.00947	CbGeAlD
Mesoridazine—HTR6—central nervous system—Parkinson's disease	0.000739	0.00945	CbGeAlD
Mesoridazine—CHRM2—cardiovascular system—Parkinson's disease	0.000717	0.00917	CbGeAlD
Mesoridazine—HTR1A—brainstem—Parkinson's disease	0.000713	0.00911	CbGeAlD
Mesoridazine—HTR1A—forebrain—Parkinson's disease	0.000688	0.00879	CbGeAlD
Mesoridazine—CYP2D6—hindbrain—Parkinson's disease	0.000675	0.00863	CbGeAlD
Mesoridazine—DRD2—brainstem—Parkinson's disease	0.000644	0.00823	CbGeAlD
Mesoridazine—DRD2—forebrain—Parkinson's disease	0.000622	0.00795	CbGeAlD
Mesoridazine—KCNH2—forebrain—Parkinson's disease	0.000613	0.00783	CbGeAlD
Mesoridazine—DRD3—brain—Parkinson's disease	0.00061	0.00779	CbGeAlD
Mesoridazine—HTR2C—medulla oblongata—Parkinson's disease	0.000591	0.00755	CbGeAlD
Mesoridazine—HTR6—brain—Parkinson's disease	0.000587	0.0075	CbGeAlD
Mesoridazine—HTR1A—cardiovascular system—Parkinson's disease	0.000582	0.00744	CbGeAlD
Mesoridazine—HTR2C—midbrain—Parkinson's disease	0.00054	0.0069	CbGeAlD
Mesoridazine—HTR2C—spinal cord—Parkinson's disease	0.000527	0.00673	CbGeAlD
Mesoridazine—KCNH2—cardiovascular system—Parkinson's disease	0.000518	0.00662	CbGeAlD
Mesoridazine—HRH1—forebrain—Parkinson's disease	0.000491	0.00627	CbGeAlD
Mesoridazine—CHRM2—head—Parkinson's disease	0.000486	0.00621	CbGeAlD
Mesoridazine—HTR2C—head—Parkinson's disease	0.000468	0.00598	CbGeAlD
Mesoridazine—HTR2A—embryo—Parkinson's disease	0.000464	0.00593	CbGeAlD
Mesoridazine—CHRM2—nervous system—Parkinson's disease	0.00046	0.00588	CbGeAlD
Mesoridazine—HTR1A—midbrain—Parkinson's disease	0.000454	0.00581	CbGeAlD
Mesoridazine—HTR2C—nervous system—Parkinson's disease	0.000444	0.00567	CbGeAlD
Mesoridazine—HTR1A—spinal cord—Parkinson's disease	0.000443	0.00567	CbGeAlD
Mesoridazine—CHRM2—central nervous system—Parkinson's disease	0.000443	0.00566	CbGeAlD
Mesoridazine—KCNH2—medulla oblongata—Parkinson's disease	0.000443	0.00566	CbGeAlD
Mesoridazine—HTR2C—central nervous system—Parkinson's disease	0.000427	0.00546	CbGeAlD
Mesoridazine—HTR2A—brainstem—Parkinson's disease	0.000425	0.00543	CbGeAlD
Mesoridazine—DRD2—midbrain—Parkinson's disease	0.000411	0.00525	CbGeAlD
Mesoridazine—HTR2A—forebrain—Parkinson's disease	0.00041	0.00524	CbGeAlD
Mesoridazine—KCNH2—midbrain—Parkinson's disease	0.000405	0.00517	CbGeAlD
Mesoridazine—KCNH2—spinal cord—Parkinson's disease	0.000395	0.00504	CbGeAlD
Mesoridazine—HTR1A—head—Parkinson's disease	0.000394	0.00504	CbGeAlD
Mesoridazine—CYP2D6—brainstem—Parkinson's disease	0.000387	0.00495	CbGeAlD
Mesoridazine—CYP2D6—forebrain—Parkinson's disease	0.000374	0.00477	CbGeAlD
Mesoridazine—HTR1A—nervous system—Parkinson's disease	0.000374	0.00477	CbGeAlD
Mesoridazine—HTR1A—central nervous system—Parkinson's disease	0.00036	0.0046	CbGeAlD
Mesoridazine—DRD2—head—Parkinson's disease	0.000356	0.00455	CbGeAlD
Mesoridazine—CHRM2—brain—Parkinson's disease	0.000352	0.0045	CbGeAlD
Mesoridazine—HTR1A—cerebellum—Parkinson's disease	0.000352	0.00449	CbGeAlD
Mesoridazine—KCNH2—head—Parkinson's disease	0.000351	0.00448	CbGeAlD
Mesoridazine—HTR2A—cardiovascular system—Parkinson's disease	0.000347	0.00443	CbGeAlD
Mesoridazine—HTR2C—brain—Parkinson's disease	0.000339	0.00433	CbGeAlD
Mesoridazine—DRD2—nervous system—Parkinson's disease	0.000338	0.00431	CbGeAlD
Mesoridazine—KCNH2—nervous system—Parkinson's disease	0.000333	0.00425	CbGeAlD
Mesoridazine—DRD2—central nervous system—Parkinson's disease	0.000325	0.00415	CbGeAlD
Mesoridazine—KCNH2—central nervous system—Parkinson's disease	0.00032	0.00409	CbGeAlD
Mesoridazine—DRD2—cerebellum—Parkinson's disease	0.000318	0.00406	CbGeAlD
Mesoridazine—KCNH2—cerebellum—Parkinson's disease	0.000313	0.004	CbGeAlD
Mesoridazine—HTR2A—medulla oblongata—Parkinson's disease	0.000296	0.00379	CbGeAlD
Mesoridazine—HTR1A—brain—Parkinson's disease	0.000286	0.00365	CbGeAlD
Mesoridazine—HRH1—head—Parkinson's disease	0.000281	0.00359	CbGeAlD
Mesoridazine—HTR2A—midbrain—Parkinson's disease	0.000271	0.00346	CbGeAlD
Mesoridazine—HRH1—nervous system—Parkinson's disease	0.000267	0.00341	CbGeAlD
Mesoridazine—HTR2A—spinal cord—Parkinson's disease	0.000264	0.00338	CbGeAlD
Mesoridazine—DRD2—brain—Parkinson's disease	0.000258	0.0033	CbGeAlD
Mesoridazine—HRH1—central nervous system—Parkinson's disease	0.000257	0.00328	CbGeAlD
Mesoridazine—KCNH2—brain—Parkinson's disease	0.000254	0.00325	CbGeAlD
Mesoridazine—Acetophenazine—DRD1—Parkinson's disease	0.000243	0.0326	CrCbGaD
Mesoridazine—HTR2A—head—Parkinson's disease	0.000235	0.003	CbGeAlD
Mesoridazine—HTR2A—nervous system—Parkinson's disease	0.000223	0.00284	CbGeAlD
Mesoridazine—Propericiazine—DRD1—Parkinson's disease	0.000214	0.0288	CrCbGaD
Mesoridazine—HTR2A—central nervous system—Parkinson's disease	0.000214	0.00274	CbGeAlD
Mesoridazine—CYP2D6—head—Parkinson's disease	0.000214	0.00273	CbGeAlD
Mesoridazine—Eletriptan—HTR7—Parkinson's disease	0.000213	0.0286	CrCbGaD
Mesoridazine—HTR2A—cerebellum—Parkinson's disease	0.000209	0.00268	CbGeAlD
Mesoridazine—HRH1—brain—Parkinson's disease	0.000204	0.0026	CbGeAlD
Mesoridazine—CYP2D6—nervous system—Parkinson's disease	0.000203	0.00259	CbGeAlD
Mesoridazine—CYP2D6—central nervous system—Parkinson's disease	0.000195	0.0025	CbGeAlD
Mesoridazine—Encainide—CYP2D6—Parkinson's disease	0.000195	0.0262	CrCbGaD
Mesoridazine—CYP2D6—cerebellum—Parkinson's disease	0.000191	0.00244	CbGeAlD
Mesoridazine—Acetophenazine—DRD2—Parkinson's disease	0.000171	0.023	CrCbGaD
Mesoridazine—HTR2A—brain—Parkinson's disease	0.00017	0.00217	CbGeAlD
Mesoridazine—Eletriptan—HTR1A—Parkinson's disease	0.000163	0.0219	CrCbGaD
Mesoridazine—CYP2D6—brain—Parkinson's disease	0.000155	0.00198	CbGeAlD
Mesoridazine—Triflupromazine—DRD1—Parkinson's disease	0.000149	0.02	CrCbGaD
Mesoridazine—Clemastine—CYP2D6—Parkinson's disease	0.000145	0.0195	CrCbGaD
Mesoridazine—Acepromazine—DRD1—Parkinson's disease	0.000138	0.0185	CrCbGaD
Mesoridazine—Thioproperazine—DRD1—Parkinson's disease	0.000135	0.0181	CrCbGaD
Mesoridazine—Pipotiazine—DRD1—Parkinson's disease	0.000132	0.0178	CrCbGaD
Mesoridazine—Thiothixene—DRD1—Parkinson's disease	0.000132	0.0178	CrCbGaD
Mesoridazine—Prochlorperazine—DRD3—Parkinson's disease	0.000129	0.0173	CrCbGaD
Mesoridazine—Cyamemazine—HTR2A—Parkinson's disease	0.000117	0.0157	CrCbGaD
Mesoridazine—Fluphenazine—DRD3—Parkinson's disease	0.000117	0.0157	CrCbGaD
Mesoridazine—Fluphenazine—DRD1—Parkinson's disease	0.000114	0.0154	CrCbGaD
Mesoridazine—Acepromazine—HTR1A—Parkinson's disease	0.000114	0.0154	CrCbGaD
Mesoridazine—Thioproperazine—HTR1A—Parkinson's disease	0.000112	0.015	CrCbGaD
Mesoridazine—Propiomazine—DRD1—Parkinson's disease	0.00011	0.0148	CrCbGaD
Mesoridazine—Pipotiazine—HTR1A—Parkinson's disease	0.00011	0.0148	CrCbGaD
Mesoridazine—Thiothixene—HTR1A—Parkinson's disease	0.00011	0.0148	CrCbGaD
Mesoridazine—Thioridazine—HTR7—Parkinson's disease	0.000107	0.0144	CrCbGaD
Mesoridazine—Triflupromazine—DRD2—Parkinson's disease	0.000105	0.0141	CrCbGaD
Mesoridazine—Thioridazine—DRD1—Parkinson's disease	9.86e-05	0.0133	CrCbGaD
Mesoridazine—Perphenazine—HTR7—Parkinson's disease	9.81e-05	0.0132	CrCbGaD
Mesoridazine—Eletriptan—CYP2D6—Parkinson's disease	9.79e-05	0.0132	CrCbGaD
Mesoridazine—Acepromazine—DRD2—Parkinson's disease	9.71e-05	0.0131	CrCbGaD
Mesoridazine—Methotrimeprazine—DRD3—Parkinson's disease	9.59e-05	0.0129	CrCbGaD
Mesoridazine—Fluphenazine—HTR1A—Parkinson's disease	9.51e-05	0.0128	CrCbGaD
Mesoridazine—Thioproperazine—DRD2—Parkinson's disease	9.49e-05	0.0128	CrCbGaD
Mesoridazine—Methotrimeprazine—DRD1—Parkinson's disease	9.42e-05	0.0127	CrCbGaD
Mesoridazine—Thiothixene—DRD2—Parkinson's disease	9.34e-05	0.0126	CrCbGaD
Mesoridazine—Pipotiazine—DRD2—Parkinson's disease	9.34e-05	0.0126	CrCbGaD
Mesoridazine—Mequitazine—CYP2D6—Parkinson's disease	9.28e-05	0.0125	CrCbGaD
Mesoridazine—Perphenazine—DRD1—Parkinson's disease	9.05e-05	0.0122	CrCbGaD
Mesoridazine—Prochlorperazine—DRD2—Parkinson's disease	8.92e-05	0.012	CrCbGaD
Mesoridazine—Thioridazine—HTR1A—Parkinson's disease	8.19e-05	0.011	CrCbGaD
Mesoridazine—Promazine—DRD1—Parkinson's disease	8.16e-05	0.011	CrCbGaD
Mesoridazine—Fluphenazine—DRD2—Parkinson's disease	8.07e-05	0.0108	CrCbGaD
Mesoridazine—Chlorpromazine—HTR7—Parkinson's disease	7.78e-05	0.0105	CrCbGaD
Mesoridazine—Fluphenazine—CYP2E1—Parkinson's disease	7.77e-05	0.0104	CrCbGaD
Mesoridazine—Propiomazine—DRD2—Parkinson's disease	7.76e-05	0.0104	CrCbGaD
Mesoridazine—Trifluoperazine—HTR1A—Parkinson's disease	7.6e-05	0.0102	CrCbGaD
Mesoridazine—Perphenazine—HTR1A—Parkinson's disease	7.52e-05	0.0101	CrCbGaD
Mesoridazine—Acepromazine—HTR2A—Parkinson's disease	7.5e-05	0.0101	CrCbGaD
Mesoridazine—Thioproperazine—HTR2A—Parkinson's disease	7.33e-05	0.00986	CrCbGaD
Mesoridazine—Chlorpromazine—DRD3—Parkinson's disease	7.32e-05	0.00984	CrCbGaD
Mesoridazine—Pipotiazine—HTR2A—Parkinson's disease	7.22e-05	0.0097	CrCbGaD
Mesoridazine—Thiothixene—HTR2A—Parkinson's disease	7.22e-05	0.0097	CrCbGaD
Mesoridazine—Chlorpromazine—DRD1—Parkinson's disease	7.18e-05	0.00965	CrCbGaD
Mesoridazine—Eletriptan—ABCB1—Parkinson's disease	6.99e-05	0.00939	CrCbGaD
Mesoridazine—Thioridazine—DRD2—Parkinson's disease	6.95e-05	0.00935	CrCbGaD
Mesoridazine—Thioridazine—CYP2E1—Parkinson's disease	6.69e-05	0.009	CrCbGaD
Mesoridazine—Methotrimeprazine—DRD2—Parkinson's disease	6.64e-05	0.00892	CrCbGaD
Mesoridazine—Thiothixene—CYP2D6—Parkinson's disease	6.6e-05	0.00887	CrCbGaD
Mesoridazine—Pipotiazine—CYP2D6—Parkinson's disease	6.6e-05	0.00887	CrCbGaD
Mesoridazine—Promethazine—DRD2—Parkinson's disease	6.54e-05	0.00879	CrCbGaD
Mesoridazine—Trifluoperazine—DRD2—Parkinson's disease	6.45e-05	0.00867	CrCbGaD
Mesoridazine—Methotrimeprazine—CYP2E1—Parkinson's disease	6.39e-05	0.00859	CrCbGaD
Mesoridazine—Perphenazine—DRD2—Parkinson's disease	6.38e-05	0.00858	CrCbGaD
Mesoridazine—Prochlorperazine—CYP2D6—Parkinson's disease	6.31e-05	0.00848	CrCbGaD
Mesoridazine—Fluphenazine—HTR2A—Parkinson's disease	6.24e-05	0.00838	CrCbGaD
Mesoridazine—Propiomazine—HTR2A—Parkinson's disease	6e-05	0.00806	CrCbGaD
Mesoridazine—Chlorpromazine—HTR1A—Parkinson's disease	5.96e-05	0.00802	CrCbGaD
Mesoridazine—Promazine—DRD2—Parkinson's disease	5.75e-05	0.00773	CrCbGaD
Mesoridazine—Fluphenazine—CYP2D6—Parkinson's disease	5.7e-05	0.00767	CrCbGaD
Mesoridazine—Thioridazine—HTR2A—Parkinson's disease	5.37e-05	0.00722	CrCbGaD
Mesoridazine—Triflupromazine—ABCB1—Parkinson's disease	5.3e-05	0.00712	CrCbGaD
Mesoridazine—Methotrimeprazine—HTR2A—Parkinson's disease	5.13e-05	0.0069	CrCbGaD
Mesoridazine—Chlorpromazine—DRD2—Parkinson's disease	5.06e-05	0.00681	CrCbGaD
Mesoridazine—Promethazine—HTR2A—Parkinson's disease	5.05e-05	0.00679	CrCbGaD
Mesoridazine—Trifluoperazine—HTR2A—Parkinson's disease	4.99e-05	0.0067	CrCbGaD
Mesoridazine—Perphenazine—HTR2A—Parkinson's disease	4.93e-05	0.00663	CrCbGaD
Mesoridazine—Thioridazine—CYP2D6—Parkinson's disease	4.91e-05	0.00661	CrCbGaD
Mesoridazine—Chlorpromazine—CYP2E1—Parkinson's disease	4.87e-05	0.00655	CrCbGaD
Mesoridazine—Methotrimeprazine—CYP2D6—Parkinson's disease	4.69e-05	0.00631	CrCbGaD
Mesoridazine—Promethazine—CYP2D6—Parkinson's disease	4.62e-05	0.00621	CrCbGaD
Mesoridazine—Perphenazine—CYP2D6—Parkinson's disease	4.51e-05	0.00606	CrCbGaD
Mesoridazine—Promazine—HTR2A—Parkinson's disease	4.45e-05	0.00598	CrCbGaD
Mesoridazine—Fluphenazine—ABCB1—Parkinson's disease	4.07e-05	0.00547	CrCbGaD
Mesoridazine—Chlorpromazine—HTR2A—Parkinson's disease	3.91e-05	0.00526	CrCbGaD
Mesoridazine—Chlorpromazine—CYP2D6—Parkinson's disease	3.58e-05	0.00481	CrCbGaD
Mesoridazine—Promethazine—ABCB1—Parkinson's disease	3.3e-05	0.00444	CrCbGaD
Mesoridazine—Trifluoperazine—ABCB1—Parkinson's disease	3.26e-05	0.00438	CrCbGaD
Mesoridazine—Chlorpromazine—ABCB1—Parkinson's disease	2.55e-05	0.00343	CrCbGaD
Mesoridazine—HTR6—Signaling by GPCR—HTR2A—Parkinson's disease	2.06e-05	0.000185	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—MAG—Parkinson's disease	2.06e-05	0.000185	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—PENK—Parkinson's disease	2.06e-05	0.000185	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—HTR1A—Parkinson's disease	2.06e-05	0.000184	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—GRM5—Parkinson's disease	2.05e-05	0.000184	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—DRD3—Parkinson's disease	2.04e-05	0.000183	CbGpPWpGaD
Mesoridazine—HTR2A—SIDS Susceptibility Pathways—IL6—Parkinson's disease	2.04e-05	0.000183	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—DRD2—Parkinson's disease	2.03e-05	0.000183	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—HTR7—Parkinson's disease	2.03e-05	0.000183	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—TAC1—Parkinson's disease	2.02e-05	0.000182	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—ADORA2A—Parkinson's disease	2.01e-05	0.000181	CbGpPWpGaD
Mesoridazine—CHRM2—SIDS Susceptibility Pathways—IL6—Parkinson's disease	2.01e-05	0.00018	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—EDN1—Parkinson's disease	2e-05	0.00018	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—DRD1—Parkinson's disease	1.98e-05	0.000178	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—ADRBK1—Parkinson's disease	1.97e-05	0.000177	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—GBA—Parkinson's disease	1.96e-05	0.000176	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—FBP1—Parkinson's disease	1.96e-05	0.000176	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—DBH—Parkinson's disease	1.96e-05	0.000176	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—PDYN—Parkinson's disease	1.95e-05	0.000175	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—ADRBK1—Parkinson's disease	1.94e-05	0.000174	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—ADRBK1—Parkinson's disease	1.94e-05	0.000174	CbGpPWpGaD
Mesoridazine—DRD3—GPCR downstream signaling—HTR2A—Parkinson's disease	1.93e-05	0.000173	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—DRD3—Parkinson's disease	1.92e-05	0.000173	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—EDN1—Parkinson's disease	1.92e-05	0.000172	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—PDYN—Parkinson's disease	1.92e-05	0.000172	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—HTR7—Parkinson's disease	1.91e-05	0.000172	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—PDYN—Parkinson's disease	1.91e-05	0.000172	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—EDN1—Parkinson's disease	1.91e-05	0.000171	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—ADRBK1—Parkinson's disease	1.91e-05	0.000171	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—DRD2—Parkinson's disease	1.88e-05	0.000169	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—HTR7—Parkinson's disease	1.88e-05	0.000169	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—PDYN—Parkinson's disease	1.88e-05	0.000169	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—HTR7—Parkinson's disease	1.88e-05	0.000169	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—DRD2—Parkinson's disease	1.88e-05	0.000169	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—INSR—Parkinson's disease	1.86e-05	0.000167	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—DRD2—Parkinson's disease	1.85e-05	0.000166	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—HTR7—Parkinson's disease	1.85e-05	0.000166	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—GFAP—Parkinson's disease	1.83e-05	0.000164	CbGpPWpGaD
Mesoridazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	1.82e-05	0.000163	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—GRM5—Parkinson's disease	1.81e-05	0.000162	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—FGF20—Parkinson's disease	1.81e-05	0.000162	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—GFAP—Parkinson's disease	1.8e-05	0.000162	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—FGF20—Parkinson's disease	1.8e-05	0.000161	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—GFAP—Parkinson's disease	1.8e-05	0.000161	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—ADRBK1—Parkinson's disease	1.8e-05	0.000161	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—GRM5—Parkinson's disease	1.78e-05	0.00016	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—GRM5—Parkinson's disease	1.78e-05	0.00016	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—GFAP—Parkinson's disease	1.77e-05	0.000159	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—FGB—Parkinson's disease	1.75e-05	0.000157	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—ADORA2A—Parkinson's disease	1.75e-05	0.000157	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—HTR2A—Parkinson's disease	1.75e-05	0.000157	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—GRM5—Parkinson's disease	1.75e-05	0.000157	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—HTR1A—Parkinson's disease	1.75e-05	0.000157	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—ADORA2A—Parkinson's disease	1.74e-05	0.000157	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—EDN1—Parkinson's disease	1.74e-05	0.000157	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—HTR7—Parkinson's disease	1.74e-05	0.000156	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—DRD2—Parkinson's disease	1.74e-05	0.000156	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—EDN1—Parkinson's disease	1.74e-05	0.000156	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—TAC1—Parkinson's disease	1.72e-05	0.000154	CbGpPWpGaD
Mesoridazine—DRD2—Circadian rythm related genes—IL6—Parkinson's disease	1.7e-05	0.000152	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—EDN1—Parkinson's disease	1.69e-05	0.000151	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—DRD1—Parkinson's disease	1.69e-05	0.000151	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—HTR2A—Parkinson's disease	1.68e-05	0.000151	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—HTR2A—Parkinson's disease	1.67e-05	0.00015	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—EDN1—Parkinson's disease	1.66e-05	0.000149	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—EDN1—Parkinson's disease	1.66e-05	0.000149	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—EDN1—Parkinson's disease	1.63e-05	0.000146	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—INSR—Parkinson's disease	1.62e-05	0.000145	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—INSR—Parkinson's disease	1.61e-05	0.000144	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—FGF20—Parkinson's disease	1.59e-05	0.000142	CbGpPWpGaD
Mesoridazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	1.58e-05	0.000142	CbGpPWpGaD
Mesoridazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	1.58e-05	0.000142	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—FGF20—Parkinson's disease	1.56e-05	0.00014	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—FGF20—Parkinson's disease	1.56e-05	0.00014	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—ADORA2A—Parkinson's disease	1.54e-05	0.000138	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—FGF20—Parkinson's disease	1.53e-05	0.000138	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—EDN1—Parkinson's disease	1.53e-05	0.000137	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—FGB—Parkinson's disease	1.53e-05	0.000137	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—HTR2A—Parkinson's disease	1.53e-05	0.000137	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—ADRBK1—Parkinson's disease	1.52e-05	0.000137	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—FGB—Parkinson's disease	1.52e-05	0.000137	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—HTR2A—Parkinson's disease	1.52e-05	0.000136	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—ADORA2A—Parkinson's disease	1.51e-05	0.000136	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—HTR1A—Parkinson's disease	1.51e-05	0.000136	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—ADORA2A—Parkinson's disease	1.51e-05	0.000136	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—EDN1—Parkinson's disease	1.51e-05	0.000135	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—EDN1—Parkinson's disease	1.5e-05	0.000135	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—TAC1—Parkinson's disease	1.5e-05	0.000134	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—TAC1—Parkinson's disease	1.49e-05	0.000134	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—ADORA2A—Parkinson's disease	1.49e-05	0.000133	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—EDN1—Parkinson's disease	1.48e-05	0.000133	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—HTR7—Parkinson's disease	1.48e-05	0.000133	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—DRD2—Parkinson's disease	1.48e-05	0.000133	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—HTR2A—Parkinson's disease	1.48e-05	0.000132	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—DRD1—Parkinson's disease	1.47e-05	0.000132	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—DRD1—Parkinson's disease	1.46e-05	0.000131	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—IGF2—Parkinson's disease	1.46e-05	0.000131	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—HTR2A—Parkinson's disease	1.45e-05	0.00013	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—DDC—Parkinson's disease	1.44e-05	0.000129	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—HTR2A—Parkinson's disease	1.43e-05	0.000128	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—DRD3—Parkinson's disease	1.42e-05	0.000128	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—INSR—Parkinson's disease	1.42e-05	0.000128	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—DRD3—Parkinson's disease	1.42e-05	0.000127	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—IGF1R—Parkinson's disease	1.41e-05	0.000126	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—INSR—Parkinson's disease	1.4e-05	0.000125	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—INSR—Parkinson's disease	1.39e-05	0.000125	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—EDN1—Parkinson's disease	1.39e-05	0.000125	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—INSR—Parkinson's disease	1.37e-05	0.000123	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—GSTA4—Parkinson's disease	1.36e-05	0.000122	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—FGB—Parkinson's disease	1.34e-05	0.000121	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—HTR2A—Parkinson's disease	1.34e-05	0.00012	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—HTR1A—Parkinson's disease	1.34e-05	0.00012	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—ADRBK1—Parkinson's disease	1.33e-05	0.000119	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—ADRBK1—Parkinson's disease	1.32e-05	0.000119	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—FGB—Parkinson's disease	1.32e-05	0.000119	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—FGB—Parkinson's disease	1.32e-05	0.000118	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—TAC1—Parkinson's disease	1.32e-05	0.000118	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—HTR2A—Parkinson's disease	1.32e-05	0.000118	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—HTR1A—Parkinson's disease	1.31e-05	0.000118	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—HTR1A—Parkinson's disease	1.31e-05	0.000118	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—FGB—Parkinson's disease	1.3e-05	0.000116	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—TAC1—Parkinson's disease	1.29e-05	0.000116	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—HTR2A—Parkinson's disease	1.29e-05	0.000116	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—TAC1—Parkinson's disease	1.29e-05	0.000116	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—HTR1A—Parkinson's disease	1.29e-05	0.000116	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—DRD1—Parkinson's disease	1.29e-05	0.000116	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—HTR7—Parkinson's disease	1.29e-05	0.000115	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—DRD2—Parkinson's disease	1.29e-05	0.000115	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—HTR7—Parkinson's disease	1.28e-05	0.000115	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—DRD2—Parkinson's disease	1.28e-05	0.000115	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—NGF—Parkinson's disease	1.28e-05	0.000115	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—TAC1—Parkinson's disease	1.27e-05	0.000114	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—DRD1—Parkinson's disease	1.27e-05	0.000114	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—DRD1—Parkinson's disease	1.27e-05	0.000114	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—DRD3—Parkinson's disease	1.25e-05	0.000112	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—DRD1—Parkinson's disease	1.25e-05	0.000112	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—IGF2—Parkinson's disease	1.24e-05	0.000111	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—DRD3—Parkinson's disease	1.23e-05	0.00011	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—DRD3—Parkinson's disease	1.23e-05	0.00011	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	1.22e-05	0.00011	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—HTR2A—Parkinson's disease	1.22e-05	0.000109	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—MAOB—Parkinson's disease	1.21e-05	0.000109	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—DRD3—Parkinson's disease	1.21e-05	0.000108	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—IGF1R—Parkinson's disease	1.2e-05	0.000107	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—EDN1—Parkinson's disease	1.18e-05	0.000106	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—ADRBK1—Parkinson's disease	1.17e-05	0.000105	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—ADRBK1—Parkinson's disease	1.15e-05	0.000103	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—ADRBK1—Parkinson's disease	1.15e-05	0.000103	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—APOE—Parkinson's disease	1.13e-05	0.000102	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—HTR7—Parkinson's disease	1.13e-05	0.000101	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—ADRBK1—Parkinson's disease	1.13e-05	0.000101	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—HTR7—Parkinson's disease	1.11e-05	9.98e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—DRD2—Parkinson's disease	1.11e-05	9.98e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—HTR7—Parkinson's disease	1.11e-05	9.96e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—DRD2—Parkinson's disease	1.11e-05	9.96e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—DRD2—Parkinson's disease	1.09e-05	9.8e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—HTR7—Parkinson's disease	1.09e-05	9.8e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—NGF—Parkinson's disease	1.09e-05	9.75e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—IGF2—Parkinson's disease	1.08e-05	9.68e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—IGF2—Parkinson's disease	1.07e-05	9.63e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—IGF1R—Parkinson's disease	1.04e-05	9.36e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—IGF1R—Parkinson's disease	1.04e-05	9.31e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—HTR2A—Parkinson's disease	1.03e-05	9.28e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—EDN1—Parkinson's disease	1.03e-05	9.25e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—EDN1—Parkinson's disease	1.03e-05	9.2e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—INS—Parkinson's disease	9.67e-06	8.68e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—APOE—Parkinson's disease	9.61e-06	8.63e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—IGF2—Parkinson's disease	9.47e-06	8.5e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—NGF—Parkinson's disease	9.47e-06	8.5e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—NGF—Parkinson's disease	9.42e-06	8.45e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—IGF2—Parkinson's disease	9.32e-06	8.36e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—IGF2—Parkinson's disease	9.3e-06	8.34e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—IGF1R—Parkinson's disease	9.15e-06	8.22e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—IGF2—Parkinson's disease	9.15e-06	8.21e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—EDN1—Parkinson's disease	9.05e-06	8.12e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—HTR2A—Parkinson's disease	9.01e-06	8.09e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—IGF1R—Parkinson's disease	9.01e-06	8.08e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—IGF1R—Parkinson's disease	8.99e-06	8.07e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—HTR2A—Parkinson's disease	8.97e-06	8.05e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—EDN1—Parkinson's disease	8.9e-06	7.99e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—EDN1—Parkinson's disease	8.88e-06	7.97e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—IGF1R—Parkinson's disease	8.84e-06	7.94e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—CTGF—Parkinson's disease	8.83e-06	7.93e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—EDN1—Parkinson's disease	8.74e-06	7.84e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—APOE—Parkinson's disease	8.38e-06	7.52e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—APOE—Parkinson's disease	8.34e-06	7.48e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—NGF—Parkinson's disease	8.31e-06	7.46e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	8.23e-06	7.39e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—INS—Parkinson's disease	8.21e-06	7.37e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—NGF—Parkinson's disease	8.18e-06	7.34e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—NGF—Parkinson's disease	8.16e-06	7.33e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—NQO1—Parkinson's disease	8.14e-06	7.3e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—NGF—Parkinson's disease	8.03e-06	7.21e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—TH—Parkinson's disease	8.02e-06	7.2e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—HTR2A—Parkinson's disease	7.91e-06	7.1e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—HTR2A—Parkinson's disease	7.77e-06	6.97e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—CYCS—Parkinson's disease	7.7e-06	6.91e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—HTR2A—Parkinson's disease	7.65e-06	6.86e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—APOE—Parkinson's disease	7.36e-06	6.6e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—APOE—Parkinson's disease	7.24e-06	6.5e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—APOE—Parkinson's disease	7.22e-06	6.48e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—CASP3—Parkinson's disease	7.2e-06	6.46e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—INS—Parkinson's disease	7.16e-06	6.42e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—IL6—Parkinson's disease	7.15e-06	6.42e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—INS—Parkinson's disease	7.12e-06	6.39e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—APOE—Parkinson's disease	7.11e-06	6.38e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—COMT—Parkinson's disease	6.82e-06	6.12e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—GSTP1—Parkinson's disease	6.79e-06	6.09e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—MAOA—Parkinson's disease	6.77e-06	6.08e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—HMOX1—Parkinson's disease	6.69e-06	6.01e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—MAPK8—Parkinson's disease	6.62e-06	5.94e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—ABCB1—Parkinson's disease	6.43e-06	5.77e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—INS—Parkinson's disease	6.29e-06	5.64e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—GSTM1—Parkinson's disease	6.24e-06	5.6e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—INS—Parkinson's disease	6.18e-06	5.55e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—INS—Parkinson's disease	6.17e-06	5.54e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—CASP3—Parkinson's disease	6.12e-06	5.49e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—IL6—Parkinson's disease	6.08e-06	5.45e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—INS—Parkinson's disease	6.07e-06	5.45e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—GPX1—Parkinson's disease	5.97e-06	5.36e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—MAPK8—Parkinson's disease	5.62e-06	5.04e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—MTHFR—Parkinson's disease	5.51e-06	4.95e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—CASP3—Parkinson's disease	5.33e-06	4.78e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CASP3—Parkinson's disease	5.3e-06	4.76e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—IL6—Parkinson's disease	5.3e-06	4.75e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—IL6—Parkinson's disease	5.27e-06	4.73e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—APOE—Parkinson's disease	5.13e-06	4.61e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—MAPK8—Parkinson's disease	4.9e-06	4.4e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—MAPK8—Parkinson's disease	4.87e-06	4.37e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CASP3—Parkinson's disease	4.68e-06	4.2e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—IL6—Parkinson's disease	4.65e-06	4.17e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CASP3—Parkinson's disease	4.6e-06	4.13e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CASP3—Parkinson's disease	4.59e-06	4.12e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—IL6—Parkinson's disease	4.57e-06	4.11e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—IL6—Parkinson's disease	4.56e-06	4.1e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CASP3—Parkinson's disease	4.52e-06	4.06e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—IL6—Parkinson's disease	4.49e-06	4.03e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—INS—Parkinson's disease	4.38e-06	3.94e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—MAPK8—Parkinson's disease	4.3e-06	3.86e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—MAPK8—Parkinson's disease	4.23e-06	3.8e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—IL6—Parkinson's disease	4.23e-06	3.79e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—MAPK8—Parkinson's disease	4.22e-06	3.79e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—MAPK8—Parkinson's disease	4.15e-06	3.73e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—IL6—Parkinson's disease	3.59e-06	3.22e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—IL6—Parkinson's disease	3.13e-06	2.81e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—IL6—Parkinson's disease	3.11e-06	2.79e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—IL6—Parkinson's disease	2.75e-06	2.46e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—IL6—Parkinson's disease	2.7e-06	2.43e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—IL6—Parkinson's disease	2.7e-06	2.42e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—IL6—Parkinson's disease	2.65e-06	2.38e-05	CbGpPWpGaD
